Merida Sotelo-Lerma

Title: Merida Sotelo-Lerma: Pioneering Organic Arsenicals in Cancer Treatment

Introduction

Merida Sotelo-Lerma is an innovative inventor based in Hermosillo, Mexico. She has made significant contributions to the field of cancer treatment through her research and development of organic arsenicals. With a total of 4 patents, her work focuses on creating less toxic alternatives to traditional cancer therapies.

Latest Patents

Sotelo-Lerma's latest patents include S-dimethylarsino-thiosuccinic acid, S-dimethylarsino-2-thiobenzoic acid, and S-(dimethylarsino) glutathione. These compounds have shown potent in vitro cytotoxic activity against various human tumor cell lines, including both solid and hematological origins. The development of these organic arsenic derivatives aims to provide effective cancer treatments with significantly lower toxicity compared to conventional agents like arsenic trioxide.

Career Highlights

Throughout her career, Merida Sotelo-Lerma has worked with prestigious institutions such as the Texas A&M University System and the University of Texas System. Her research has laid the groundwork for the potential use of organic arsenicals as a viable anti-cancer therapy, combining high efficacy with minimal toxicity.

Collaborations

Sotelo-Lerma has collaborated with notable professionals in her field, including Ralph A. Zingaro and Emil J. Freireich. These partnerships have further enhanced her research and contributed to the advancement of cancer treatment methodologies.

Conclusion

Merida Sotelo-Lerma's innovative work in developing organic arsenicals represents a significant advancement in cancer therapy. Her contributions are paving the way for safer and more effective treatment options for patients.